126 related articles for article (PubMed ID: 6987605)
1. Syngeneic bone marrow transplantation in a patient with metastatic neuroblastoma refractory to conventional therapy.
Spruce WE; Blume KG; Ellington OB; Schmidt GM; Zusman J
Pediatrics; 1980 Mar; 65(3):573-4. PubMed ID: 6987605
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
[TBL] [Abstract][Full Text] [Related]
3. Attempted treatment of a child with metastatic neuroblastoma employing syngeneic marrow transplantation.
Klemperer MR; Ganick D; Shigeoka A; Lee H; Segel G
Transplantation; 1976 Feb; 21(2):161-4. PubMed ID: 766334
[No Abstract] [Full Text] [Related]
4. Graft-versus-tumour effect in refractory metastatic neuroblastoma.
Marabelle A; Paillard C; Tchirkov A; Halle P; Chassagne J; Deméocq F; Kanold J
Bone Marrow Transplant; 2007 Jun; 39(12):809-10. PubMed ID: 17450181
[No Abstract] [Full Text] [Related]
5. Autologous bone marrow transplantation. A maximal therapy design for disseminated neuroblastoma.
Helson L
Am J Pediatr Hematol Oncol; 1985; 7(1):45-50. PubMed ID: 3898900
[TBL] [Abstract][Full Text] [Related]
6. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
7. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
8. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
9. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.
D'Angio GJ; August C; Elkins W; Evans AE; Seeger R; Lenarsky C; Feig S; Wells J; Ramsay N; Kim T
Prog Clin Biol Res; 1985; 175():557-63. PubMed ID: 3887431
[No Abstract] [Full Text] [Related]
10. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
11. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
12. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
Matthay KK
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution.
August CS; Serota FT; Koch PA; Burkey E; Schlesinger H; Elkins WL; Evans AE; D'Angio GJ
J Clin Oncol; 1984 Jun; 2(6):609-16. PubMed ID: 6374056
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
[No Abstract] [Full Text] [Related]
16. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
17. [Effective combination chemotherapy with rituximab for acute lymphoblastic leukemia with bone relapse after bone marrow transplantation].
Abe T; Kitajima T; Honma K; Kurasaki T; Okazuka K; Shibasaki Y; Momoi A; Kuroha T; Masuko M; Yagisawa K; Furukawa T; Toba K; Aizawa Y
Rinsho Ketsueki; 2008 Nov; 49(11):1556-61. PubMed ID: 19047788
[TBL] [Abstract][Full Text] [Related]
18. Intensification of induction prior to intensification of consolidation and bone marrow rescue in disseminated neuroblastoma.
Paolucci P; Mancini AF; Rosito P; Vecchi V; Vivarelli F; Granchi D; Calzolari P; Paolucci G
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():151-2. PubMed ID: 2697429
[No Abstract] [Full Text] [Related]
19. Pain palliation with strontium-89 in children with metastatic disease.
Charron M; Brown M; Rowland P; Mirro J
Med Pediatr Oncol; 1996 Jun; 26(6):393-6. PubMed ID: 8614375
[TBL] [Abstract][Full Text] [Related]
20. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
Sari O; Uğur O; Emir S; Akyüz C
Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
